pillbase.ru

Linzess

Active substance: linaclotide

CAPSULE, GELATIN COATED · LINACLOTIDE 290 ug/1

United StatesActive

Marketing holder: Allergan, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Линзелакс®-Про
    капсулы, 145 мкг (original in Russian, GRLS)
    ЛП-№(015557)-(РГ-RU)
    Общество с ограниченной ответственностью "ПРОМОМЕД РУС" (ООО "ПРОМОМЕД РУС")
EU 1
  • Constella
    linaclotide
    EMEA/H/C/002490
    AbbVie Deutschland GmbH & Co. KG
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-ef51-70b0-9232-f74f781a38d6;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-9a47-7608-8253-5a83a3271e46,01a12099-a942-7f71-810b-0a6d3e99a0aa,01a1209b-f10c-729b-b972-e891fa97e80f;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0456-1202
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0456-1202 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0456-1202 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0456-1202 · Verified 2026-10-09 · open in source